Dietary advanced glycation end products modify gut microbial composition and partially increase colon permeability in rats

Molecular Nutrition and Food Research

Volumn 61, Issue 10, 2017, Pages

  Qu, Wanting ^a   Yuan, Xiaojin ^a   Zhao, Jinsong ^a   Zhang, Yingxiao ^a   Hu, Jing ^a   Wang, Jiawei ^b   Li, Juxiu ^a  

^a NORTHWEST A F UNIVERSITY   (China)

^b SHAANXI RESEARCH INSTITUTE OF AGRICULTURAL PRODUCTS PROCESSING TECHNOLOGY   (China)

Author keywords

Advanced glycation end products (AGEs); Cecal microbiota; Colon permeability; Dietary; Microbial metabolite

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMMONIA; BACTERIAL DNA; OCCLUDIN; OCLN PROTEIN, RAT; PROTEIN ZO1; RNA 16S; TJP1 PROTEIN, RAT; VOLATILE FATTY ACID;

ANIMAL; BACTEROIDETES; COLON; CYANOBACTERIUM; DIET; DNA SEQUENCE; DRUG EFFECT; FERMENTATION; FIRMICUTES; GENETICS; INTESTINE FLORA; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIOLOGY; PERMEABILITY; PROTEOBACTERIA; RAT; SPRAGUE DAWLEY RAT; VERRUCOMICROBIA;

AMMONIA; ANIMALS; BACTEROIDETES; COLON; CYANOBACTERIA; DIET; DNA, BACTERIAL; FATTY ACIDS, VOLATILE; FERMENTATION; FIRMICUTES; GASTROINTESTINAL MICROBIOME; GLYCATION END PRODUCTS, ADVANCED; MALE; OCCLUDIN; PERMEABILITY; PROTEOBACTERIA; RATS; RATS, SPRAGUE-DAWLEY; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; VERRUCOMICROBIA; ZONULA OCCLUDENS-1 PROTEIN;

EID: 85026474531     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201700118     Document Type: Article

References (71)

1. Rooks, M. G., Garrett, W. S., Gut microbiota, metabolites and host immunity. Nat. Rev. Immunol. 2016, 16, 341–352.
2. Shen, J., Obin, M. S., Zhao, L., The gut microbiota, obesity and insulin resistance. Mol. Aspects Med. 2013, 34, 39–58.
3. Tilg, H., Moschen, A. R., Microbiota and diabetes: an evolving relationship. Gut 2014, 63, 1513–1521.
4. Zhu, W., Gregory, J. C., Org, E., Buffa, J. A. et al., Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 2016, 165, 111–124.
5. Vaziri, N. D., Zhao, Y., Pahl, M. V., Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment. Nephrol. Dial Transpl. 2016, 31, 737–746.
6. Power, S. E., O'Toole, P. W., Stanton, C., Ross, R. P., Fitzgerald, G. F., Intestinal microbiota, diet and health. Brit. J.Nutr. 2014, 111, 387–402.
7. Scott, K. P., Gratz, S. W., Sheridan, P. O., Flint, H. J., Duncan, S. H., The influence of diet on the gut microbiota. Pharmacol. Res. 2013, 69, 52–60.
8. Filippo, C. D., Cavalieri, D., Paola, M. D., Ramazzotti, M. et al., Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. USA 2010, 107, 14691–14696.
9. Uribarri, J., Woodruff, S., Goodman, S., Cai, W. et al., Advanced glycation end products in foods and a practical guide to their reduction in the diet. J. Am. Dietetic Assoc. 2010, 110, 911–916.
10. Lapolla, A., Traldi, P., Fedele, D., Importance of measuring products of non-enzymatic glycation of proteins. Clin. Biochem. 2005, 38, 103–115.
11. Zhang, G., Huang, G., Xiao, L., Mitchell, A. E., Determination of advanced glycationendproducts by LC-MS/MS in raw and roasted almonds (Prunusdulcis). J. Agr. Food Chem. 2011, 59, 12037–12046.
12. Birlouez-Aragon, I., Saavedra, G., Tessier, F. J., Galinier, A. et al., A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. Am. J. Clin. Nutr. 2010, 91, 1220–1226.
13. Clarke, R., Dordevic, A., Tan, S., Ryan, L., Coughlan, M., Dietary advanced glycation end products and risk factors for chronic disease: a systematic review of randomised controlled trials. Nutrients 2016, 8, 125.
14. Chuang, Y., Wu, M., Wu, T., Su, Y., Lee, Y., Pyridoxamine ameliorates the effects of advanced glycation end products on subtotal nephrectomy induced chronic renal failure rats. J. Funct. Foods 2012, 4, 679–686.
15. Hellwig, M., Matthes, R., Peto, A., Löbner, J., Henle, T., N-Ɛ-fructosyllysine and N-Ɛ-carboxymethyllysine, but not lysinoalanine, are available for absorption after simulated gastrointestinal digestion. Amino Acids 2014, 46, 289–299.
16. Corpet, D. E., Yin, Y., Zhang, X. M., Rémésy, C. et al., Colonic protein fermentation and promotion of colon carcinogenesis by thermolyzed casein. Nutr. Cancer 1995, 23, 271–281.
17. Faist, V., Erbersdobler, H. F., Metabolic transit and in vivo effects of melanoidins and precursor compounds deriving from the Maillard reaction. Ann. Nutr. Metab. 2001, 45, 1–12.
18. Kellow, N. J., Coughlan, M. T., Effect of diet-derived advanced glycation end products on inflammation. Nutr. Rev. 2015, 73, 737–759.
19. Ahmed, N., Mirshekar-Syahkal, B., Kennish, L., Karachalias, N. et al., Assay of advanced glycationendproducts in selected beverages and food by liquid chromatography with tandem mass spectrometric detection. Mol. Nutr. Food Res. 2005, 49, 691–699.
20. Deppe, V. M., Bongaerts, J., OConnell, T., Maurer, K., Meinhardt, F., Enzymatic deglycation of Amadori products in bacteria: mechanisms, occurrence and physiological functions. Appl. Microbiol. Biotechnol. 2011, 90, 399–406.
21. Monnier, V. M., Bacterial enzymes that can deglycate glucose- and fructose-modified lysine. Biochem. J. 2005, 392, 1–3.
22. Hellwig, M., Bunzel, D., Huch, M., Franz, C. M. A. P. et al., Stability of individual Maillard reaction products in the presence of the human colonic microbiota. J. Agr. Food Chem. 2015, 63, 6723–6730.
23. Ɛ-carboxymethyllysine in young human volunteers. Amino. Acids 2012, 43, 595–602.
24. Ɛ -carboxymethyllysine in rats. Amino Acids 2013, 44, 1441–1449.
25. Dominika, Ś., Arjan, N., Karyn, R. P., Henryk, K., The study on the impact of glycated pea proteins on human intestinal bacteria. Int. J. Food Microbiol. 2011, 145, 267–272.
26. Borrelli, R. C., Fogliano, V., Bread crust melanoidins as potential prebiotic ingredients. Mol. Nutr. Food Res. 2005, 49, 673–678.
27. Mills, D. J., Tuohy, K. M., Booth, J., Buck, M. et al., Dietary glycated protein modulates the colonic microbiota towards a more detrimental composition in ulcerative colitis patients and non-ulcerative colitis subjects. J. Appl. Microbiol. 2008, 105, 706–714.
28. Seiquer, I., Rubio, L. A., Peinado, M. J., Delgado-Andrade, C., Navarro, M. P., Maillard reaction products modulate gut microbiota composition in adolescents. Mol. Nutr. Food Res. 2014, 58, 1552–1560.
29. Marungruang, N., Fåk, F., Tareke, E., Heat-treated high-fat diet modifies gut microbiota and metabolic markers in apoe−/− mice. Nutr. Metab. 2016, 13, 22.
30. Delzenne, N. M., Cani, P. D., Interaction between obesity and the gut microbiota: relevance in nutrition. Annu. Rev. Nutr. 2011, 31, 15–31.
31. Mafra, D., Lobo, J. C., Barros, A. F., Koppe, L. et al., Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease. Future Microbiol. 2014, 9, 399–410.
32. Van Nuenen, M. H. M. C., Venema, K., Van Der Woude, J. C. J., Kuipers, E. J., The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease. Digest Dis. Sci. 2004, 49, 485–491.
33. Trivedi, P. P., Jena, G. B., Dextran sulfate sodium-induced ulcerative colitis leads to increased hematopoiesis and induces both local as well as systemic genotoxicity in mice. Mutation Res. /Genetic Toxicol. Environ.Mutagen. 2012, 744, 172–183.
34. Shangari, N., Depeint, F., Furrer, R., Bruce, W. R. et al., A thermolyzed diet increases oxidative stress, plasma α-aldehydes and colonic inflammation in the rat. Chem.-Biol. Interact. 2007, 169, 100–109.
35. Trivedi, P. P., Jena, G. B., Role of α-lipoic acid in dextran sulfate sodium-induced ulcerative colitis in mice: Studies on inflammation, oxidative stress, DNA damage and fibrosis. Food. Chem. Toxicol. 2013, 59, 339–355.
36. Pendyala, S., Walker, J. M., Holt, P. R., A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology 2012, 142, 1100–1101.
37. Zheng, F., He, C., Cai, W., Hattori, M. et al., Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products. Diabetes/Metab.Res. Rev. 2002, 18, 224–237.
38. Reeves, P. G., Nielsen, F. H., Fahey, G. C., AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Aa Hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993, 123, 1939–1951.
39. Delgado-Andrade, C., Rufian-Henares, J. A., Morales, F. J., Study on fluorescence of Maillard reaction compounds in breakfast cereals. Mol. Nutr. Food Res. 2006, 50, 799–804.
40. Sun, X., Tang, J., Wang, J., Rasco, B. A. et al., Formation of advanced glycationendproducts in ground beef under pasteurisation conditions. Food Chem. 2015, 172, 802–807.
41. Ɛ-carboxymethyllysine in milk products by a modified reversed-phase HPLC method. Food Chem. 1999, 65, 547–553.
42. Ngo, T. T., Phan, A. P. H., Yam, C. F., Lenhoff, H. M., Interference in determination of ammonia with the hypochlorite-alkaline phenol method of Berthelot. Anal. Chem. 1982, 54, 46–49.
43. Schneider, S., Girardpipau, F., Anty, R., Vanderlinde, E. et al., Effects of total enteral nutrition supplemented with a multi-fibre mix on faecal short-chain fatty acids and microbiota. Clin. Nutr. 2006, 25, 82–90.
44. Yoshihara, K., Yajima, T., Kubo, C., Yoshikai, Y., Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice. Gut 2006, 55, 334–341.
45. Zhong, W., Li, Q., Sun, Q., Zhang, W. et al., Preventing gut leakiness and endotoxemia contributes to the protective effect of zinc on alcohol-induced steatohepatitis in rats. J. Nutr. 2015, 145, 2690–2698.
46. Cordain, L., Eaton, S. B., Sebastian, A., Mann, N. et al., Origins and evolution of the Western diet: health implications for the 21st century. Am. J. Clin. Nutr. 2005, 81, 341–354.
47. Ɛ-(carboxymethyl)lysine content of foods commonly consumed in a Western style diet. Food Chem. 2012, 131, 170–174.
48. Tuohy, K. M., Hinton, D. J. S., Davies, S. J., Crabbe, M. J. C. et al., Metabolism of Maillard reaction products by the human gut microbiota - implications for health. Mol. Nutr. Food Res. 2006, 50, 847–857.
49. Delgado-Andrade, C., Seiquer, I., García, M. M., Galdó, G., Navarro, M. P., Increased intake of Maillard reaction products reduces phosphorous digestibility in male adolescents. Nutrition 2011, 27, 86–91.
50. Andriamihaja, M., Davila, A. M., Eklou-Lawson, M., Petit, N. et al., Colon luminal content and epithelial cell morphology are markedly modified in rats fed with a high-protein diet. AJP: Gastrointest. Liver Physiol. 2010, 299, G1030–G1037.
51. Liu, X., Zhang, H. R., Yang, F. L., Effect of high amylose corn starch on intestinal fermentation in rats. ActaNutrimentaSinica 2007, 29, 372–375.
52. Chapman-Kiddell, C. A., Davies, P. S. W., Gillen, L., Radford-Smith, G. L., Role of diet in the development of inflammatory bowel disease. Inflamm. Bowel Dis. 2010, 16, 137–151.
53. Zhong, Y., Nyman, M., Fåk, F., Modulation of gut microbiota in rats fed high-fat diets by processing whole-grain barley to barley malt. Mol. Nutr. Food Res. 2015, 59, 2066–2076.
54. Wallace, R. J., McKain, N., Peptidase activity of human colonic bacteria. Anaerobe 1997, 3, 251–257.
55. Zackular, J. P., Rogers, M. A. M., Ruffin, M. T., Schloss, P. D., The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev. Res. 2014, 7, 1112–1121.
56. Theriot, C. M., Bowman, A. A., Young, V. B., Antibiotic-induced alterations of the gut microbiota alter secondary bile acid production and allow for Clostridium difficile spore germination and outgrowth in the large intestine. mSphere 2016, 1, e00045-15.
57. Carbonero, F., Benefiel, A. C., Alizadeh-Ghamsari, A. H., Gaskins, H. R., Microbial pathways in colonic sulfur metabolism and links with health and disease. Front. Physiol. 2012, 3, 448.
58. Lam, Y. Y., Ha, C. W. Y., Campbell, C. R., Mitchell, A. J. et al., Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One 2012, 7, e34233.
59. Świątecka, D., Małgorzata, I., Aleksander, Ś., Henryk, K., Elżbieta, K., The impact of glycated pea proteins on bacterial adhesion. Food Res. Int. 2010, 43, 1566–1576.
60. Lallès, J., Microbiota-host interplay at the gut epithelial level, health and nutrition. J. Animal Sci. Biotechnol. 2016, 7, 66.
61. Maloy, K. J., Powrie, F., Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011, 474, 298–306.
62. Farhadi, A., Banan, A., Fields, J., Keshavarzian, A., Intestinal barrier: an interface between health and disease. J. Gastroen. Hepatol. 2003, 18, 479–497.
63. Julio-Pieper, M., Bravo, J. A., Aliaga, E., Gotteland, M., Review article: intestinal barrier dysfunction and central nervous system disorders-a controversial association. Aliment Pharm. Ther. 2014, 40, 1187–1201.
64. ɛ-carboxymethyllysine after a chronic oral exposure in mice. Mol. Nutr. Food Res. 2016, 60, 2446–2456.
65. Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T. et al., Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 2005, 83, 876–886.
66. Raman, K. G., The role of RAGE in the pathogenesis of intestinal barrier dysfunction after hemorrhagic shock. AJP: Gastrointest. Liver Physiol. 2006, 291, G556–G565.
67. Vaziri, N. D., Yuan, J., Rahimi, A., Ni, Z. et al., Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation. Nephrol. Dial Transpl. 2012, 27, 2686–2693.
68. Neis, E., Dejong, C., Rensen, S., The role of microbial amino acid metabolism in host metabolism. Nutrients 2015, 7, 2930–2946.
69. Davila, A., Blachier, F., Gotteland, M., Andriamihaja, M. et al., Intestinal luminal nitrogen metabolism: role of the gut microbiota and consequences for the host. Pharmacol. Res. 2013, 68, 95–107.
70. Kellow, N. J., Coughlan, M. T., Savige, G. S., Reid, C. M., Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial. BMC Endocr. Disord. 2014, 14, 1–12.
71. Finot, P. A., Magnenat, E., Metabolic transit of early and advanced Maillard products. Prog. Food Nutr. Sci. 1981, 5, 193–207.